BIOLIFE SOLUTIONS INC — Director's Dealing 2021

Mar 6, 2021

SEC Form 4/A — Form 4/A

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2021-02-12

Reporting Person: Schulz Marcus (Chief Revenue Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-12	Common Stock	S	2000	$41.01	Disposed	37107	Direct

Footnotes

F1: This Form 4/A is being filed to amend the Form 4 originally filed by the reporting person on February 16, 2021 solely to correct the transaction date in Column 2 on Table I. No other changes have been made to the original Form 4.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.